These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24955552)

  • 21. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.
    Inoue T; Honda M; Kawamura K; Tsuchiya K; Suzuki T; Ito K; Matsubara R; Shinohara K; Ishikane T; Sasaki K; Boku S; Fujisawa D; Ono Y; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):223-7. PubMed ID: 22504727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
    Leelahanaj T
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS).
    Munro CA; Brandt J; Sheppard JM; Steele CD; Samus QM; Steinberg M; Rabins PV; Lyketsos CG
    Am J Geriatr Psychiatry; 2004; 12(5):491-8. PubMed ID: 15353387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of sertraline on psychopathic traits.
    Dunlop BW; DeFife JA; Marx L; Garlow SJ; Nemeroff CB; Lilienfeld SO
    Int Clin Psychopharmacol; 2011 Nov; 26(6):329-37. PubMed ID: 21909028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND).
    Hedayati SS; Daniel DM; Cohen S; Comstock B; Cukor D; Diaz-Linhart Y; Dember LM; Dubovsky A; Greene T; Grote N; Heagerty P; Katon W; Kimmel PL; Kutner N; Linke L; Quinn D; Rue T; Trivedi MH; Unruh M; Weisbord S; Young BA; Mehrotra R
    Contemp Clin Trials; 2016 Mar; 47():1-11. PubMed ID: 26621218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
    Pollack MH; Van Ameringen M; Simon NM; Worthington JW; Hoge EA; Keshaviah A; Stein MB
    Am J Psychiatry; 2014 Jan; 171(1):44-53. PubMed ID: 24399428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression.
    Finkel SI; Richter EM; Clary CM; Batzar E
    Am J Geriatr Psychiatry; 1999; 7(3):221-7. PubMed ID: 10438693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression.
    Katz MM; Tekell JL; Bowden CL; Brannan S; Houston JP; Berman N; Frazer A
    Neuropsychopharmacology; 2004 Mar; 29(3):566-79. PubMed ID: 14627997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
    Arnow BA; Blasey C; Williams LM; Palmer DM; Rekshan W; Schatzberg AF; Etkin A; Kulkarni J; Luther JF; Rush AJ
    Am J Psychiatry; 2015 Aug; 172(8):743-50. PubMed ID: 25815419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders.
    Hoehn-Saric R; Schlaepfer TE; Greenberg BD; McLeod DR; Pearlson GD; Wong SH
    Psychiatry Res; 2001 Nov; 108(2):89-100. PubMed ID: 11738543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.
    Arns M; Gordon E; Boutros NN
    Clin EEG Neurosci; 2017 Jan; 48(1):33-40. PubMed ID: 26674366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression.
    Victoria LW; Whyte EM; Butters MA; Meyers BS; Alexopoulos GS; Mulsant BH; Rothschild AJ; Banerjee S; Flint AJ
    Am J Geriatr Psychiatry; 2017 Jun; 25(6):672-679. PubMed ID: 28285771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Venlafaxine-induced delirium mediated by high doses].
    del Río-Casanova L; Portela B; Díaz-Llenderrozas F
    Rev Neurol; 2015 May; 60(10):475-7. PubMed ID: 25952604
    [No Abstract]   [Full Text] [Related]  

  • 37. Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline.
    Culang-Reinlieb ME; Sneed JR; Keilp JG; Roose SP
    Int J Geriatr Psychiatry; 2012 Aug; 27(8):777-84. PubMed ID: 21919060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms.
    Spalletta G; Caltagirone C
    Funct Neurol; 2003; 18(4):227-32. PubMed ID: 15055748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depressive symptoms and alcohol consumption among nonalcoholic depression patients treated with desipramine.
    Goldstein BI; Schaffer A; Levitt A; Zaretsky A; Joffe RT; Wesson V; Bagby RM
    Can J Psychiatry; 2004 Dec; 49(12):859-62. PubMed ID: 15679210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial.
    Shapiro PA; Lespérance F; Frasure-Smith N; O'Connor CM; Baker B; Jiang JW; Dorian P; Harrison W; Glassman AH
    Am Heart J; 1999 Jun; 137(6):1100-6. PubMed ID: 10347338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.